Low “quotient” Lp(a) Concentration Mediates Autoimmune Activation and Independently Predicts Cardiometabolic Risk

201425 citationsJournal Articlebronze Open Access

Authors

Altan Onat · Istanbul University

Neslihan Çoban · Institutt for Eksperimentell Medisinsk Forskning

G. Can · Istanbul University

Murat Yüksel · Dicle University

Ahmet Karagöz · Giresun University

H. Gülru Yüksel · Istanbul University

Evin Ademoğlu ·

Abstract

Elevated cardiometabolic risk is conferred by apparently reduced circulating Lp(a) assays supporting the notion that "low" serum Lp(a), mediating autoimmune activation, is a major determinant of cardiometabolic risk.

Topics & Keywords

Lipoproteins and Cardiovascular Health Atherosclerosis and Cardiovascular Diseases Inflammatory mediators and NSAID effects

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Experimental and Clinical Endocrinology & Diabetes

Volume 123, Issue 01, pp. 11-18

DOI: 10.1055/s-0034-1385922

Field-Weighted Citation Impact: 5.14